FindTrial
Sign In

Application of contrast agent in CT angiography of congenital heart disease in low birth weight newborns

Application of contrast agent in CT angiography of congenital heart disease in low birth weight newborns

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068409
Enrollment
Unknown
Registered
2023-02-17
Start date
2019-10-08
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal heart disease

Interventions

Experimental group:The diluted concentration of normal saline is 60% of Vistapak (contrast dose: 3ml/kg), and the trigger threshold is 130
control group:Use undiluted contrast agent Vistapak (contrast dose: 2ml/kg), trigger threshold is 150

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Newborn children (3-28 days) coming to the radiology department for cardiac CTA examination.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
CT Value;—

Secondary

MeasureTime frame
Subjective evaluation of image quality;—

Countries

China

Contacts

Public ContactTang Shilong

Children's Hospital of Chongqing Medical University

sltang66@163.com+86 130 1839 1877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026